Live Breaking News & Updates on Cash Runway Through Calendar

Palatin Technologies : Phase 2 Clinical Study of PL8177 in Patients with Ulcerative Colitis Currently Expected to Start Next Quarter with Top-Line Results Expected in the Second Half Calendar 2022 (Form 8-K)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Michaelb Raizman , Paul Arndt , Carl Spana , Jamese Hattersley , J Don Wang , Prnewswire Palatin Technologies Inc , Drug Administration , Exchange Commission , American Society Of Cataract , Palatin Technologies Inc , Product Development , Securities Exchange , Association For Research , Business Development , Ulcerative Colitis Currently Expected , Start Next Quarter , Top Line Results Expected , Second Half Calendar , Cash Equivalents , Cash Runway Through Calendar , Upcoming Events , Autoimmune Programs , New Drug Application , American Society , Refractive Surgery Annual ,